Tag: Target

  • Effective Ways to Market to Teenagers and Their Parents

    Marketing has a certain set of common rules that apply to both online and offline strategies. There should always be a definite target group to which advertisers communicate their ideas instead of voicing them out to the whole global population. There are many products and services centered on teen and parent audiences who are the toughest audiences that marketers have to face…

    Read More
    http://www.associationofmarketing.org/articles/view.php?article_id=7484

    Views: 0

  • 5 Simple Ways to Re-share Your Content

    Content and information are the driving forces of the Internet. In an arena where millions of individual publishers are engaged in producing content, it becomes difficult to stand out and get noticed. Publishing unique content that is locally or globally relevant is one of the ways to drive traffic to your website. However, creating fresh content is not always easy, and websites that become stagnant will not feature in the top pages of search engine results. An easy way to keep your website agile without having to create new content each time is to re-share content. Listed below are 5 simple ways to re-share your content to target any type of audience…

    Read More
    http://www.associationofmarketing.org/articles/view.php?article_id=7345

    Views: 0

  • Schistosomiasis elimination: refocusing on snail control to sustain progress

    Schistosomiasis elimination: refocusing on snail control to sustain progress

    Substantial progress has been made during the past decade to prevent and control schistosomiasis (also known as bilharziasis) globally. The disease affects more than 230 million people, mostly in sub-Saharan Africa.

    Progress is mainly due to large-scale periodic treatment of affected populations with praziquantel, the only medicine recommended by the World Health Organization (WHO) against all forms of schistosomiasis. Regular treatment cures mild symptoms and prevents
    progression to severe, chronic disease.

    “Through progressive scale-up of periodic large-scale treatment
    to control morbidity in many endemic countries, we are closer to
    achieving the minimum target of 75% global coverage of all school‐aged
    children,
    ” said Dr Amadou Garba Djirmay, who leads WHO’s global schistosomiasis control programme. “But
    if we want to achieve elimination, we must go a step further to
    introduce snail control in hot spots and in areas targeting elimination.
    This is bound to increase impact and accelerate progress towards
    interruption of transmission
    .”

    Expansion of treatment is largely supported by donated praziquantel from Merck KGaA of up to 250 million tablets annually. In 2018, almost 78 million children were treated, representing 63% of all school‐aged children eligible for treatment.

    Transmission: role of snails

    Schistosomiasis is an acute, chronic parasitic disease caused by infection with trematode worms of the genus Schistosoma. It is prevalent in tropical and subtropical areas, especially in poor, rural communities that have little or no access to
    safe drinking‐water and basic sanitation. Infection is transmitted when people suffering from schistosomiasis contaminate freshwater sources when evacuating urine and faeces containing the parasite’s eggs.

    Once an egg comes into contact with fresh water, it releases miracidia (hatchlings) which enter a snail and produce hundreds of cercariae (larvae) daily. The cercariae enter the human body on contact with the skin and develop into adult worms.

    Besides treatment with praziquantel, eliminating snail hosts and improving sanitation are important methods for sustainable prevention of the disease. Dam and irrigation projects are known to be potential sites for outbreaks of the disease. Snail management,
    often achieved through mollusciciding, can help to reduce transmission by eliminating these intermediate snail hosts.

    Vector control

    In 2017, the World Health Assembly – WHO’s decision making body – adopted resolution WHA70.16 on the Global Vector Control
    Response, calling on Member States to develop or adapt national vector control strategies and operational plans. The strategy aims to reduce by at least 40% the incidence of vector borne diseases, including schistosomiasis, by 2025.

    In response, WHO is reinforcing snail control as part of its strategic approach to achieve the target of eliminating schistosomiasis as a public health problem and, ultimately, the goal of elimination of transmission. Snail control will complement mass
    treatment campaigns and sustain the public health impact of this core intervention.

    To facilitate implementation of snail control, in 2019 WHO published on specific, standardized procedures and criteria for efficacy
    testing and evaluation and in 2017 a manual on the use of molluscicides in the field. WHO is also planning to strengthen capacities
    of health staff in medical malacology in order to reinforce snail control activities in countries.

    In the past, molluscicides (particularly niclosamide1 based products) were widely used in schistosomiasis control programmes. For example, in China programmes largely relied on snail control for over 30 years to overcome the disease as a public
    health problem. In other parts of the world, however, snail control programmes were gradually discontinued and competencies faded away.

    “Snail control is a crucial component of the global schistosomiasis elimination strategy,” said Dr Rajpal Yadav, Scientist, WHO Department of Control of Neglected Tropical Diseases. “It
    is time we look for new snail control products that are cost–effective
    and of low risk to humans and the environment. Some efforts are being
    made to explore molluscicide compounds from plants, marine algae and
    microorganisms
    .”

    An integrated control strategy involving mass treatment with praziquantel, snail control and environmental modification, wider access to sanitation and safe water, economic and environmental development, health education and poverty-alleviation can greatly
    contribute to sustainable control and elimination of schistosomiasis.

    WHO’s new road map on neglected tropical diseases for 2021–2030, due to be launched later this year, advocates enhanced financial and political support to achieve the target of interruption of transmission. Additional research to address gaps,
    develop tools and optimize the impact of existing programmes with snail control will complement the core strategic approach.

    Schistosomiasis: forms of the disease

    There are two major forms of schistosomiasis – intestinal and urogenital.

    Intestinal schistosomiasis usually results in diarrhoea and blood in the stool; enlargement of the liver and of the spleen and portal hypertension are common in advanced cases.

    Urogenital schistosomiasis is characterized by the presence of blood in the urine. Chronic infection results in fibrosis of the bladder and ureter that can evolve to hydronephrosis and create conditions for bladder cancer.

    In women, urogenital schistosomiasis can cause vaginal bleeding, pain during sexual intercourse and nodules in the vulva, a condition now described as female genital schistosomiasis. In men, urogenital schistosomiasis can induce disease in the seminal
    vesicles and prostate.


    1Limitations with the use of formulations based on niclosamide include restrictions on the usage of water immediately after application and temporary toxicity to non-target aquatic organisms including
    fish, amphibians and invertebrates. 

     

        Schistosomiasis elimination: refocusing on snail control to sustain progress
        Read More
        https://www.who.int/news-room/detail/25-03-2020-schistosomiasis-elimination-refocusing-on-snail-control-to-sustain-progress

        Views: 0

      • Penang rickshaw peddlers to receive three-month aid payout

        Penang rickshaw peddlers to receive three-month aid payout

        Penang rickshaw peddlers to receive three-month aid payout 1

        GEORGE TOWN: The Penang government will issue full payments for April to June to rickshaw peddlers affected by the Covid-19 outbreak next month.

        State Tourism Development, Arts, Culture and Heritage Committee chairman Yeoh Soon Hin said each rickshaw peddler would receive a sum of RM500, which included an allowance of RM300 and a one-off cash assistance of RM200.

        “I have communicated with various sectors to understand the needs of the various parties and I have also conveyed the needs and recommendations to the state government to get the best help for them.

        “The payout is expected to benefit about 318 peddlers,“ he said in a statement today.

        The state government previously allocated RM100 a month to peddlers in the state to help those with no fixed income.

        Yeoh said a total of 1,367 tour guides registered with the Ministry of Tourism, Arts and Culture would also receive a one-off cash assistance worth RM500 each.

        “10,000 e-hailing drivers in Penang will also receive RM300 one-off assistance while 2,248 taxi drivers will benefit from an initial incentive payment of RM300 with an additional RM200 one-off.

        “All of these assistance is part of the Penang People’s Aid Package announced by Chief Minister Chow Kon Yeow yesterday. I will continue to monitor the situation to ensure that the people and sectors that need the most help will benefit, ” he said.

        Yesterday, Chow announced a RM75 million People’s Aid Package to be distributed to 15 target groups involving over 400,000 recipients who are affected by the Covid-19 pandemic. – Bernama

        Penang rickshaw peddlers to receive three-month aid payout
        Read More
        https://www.thesundaily.my/local/penang-rickshaw-peddlers-to-receive-three-month-aid-payout-LK2185085

        Views: 0

      • WHO satisfied with Malaysia’s preparedness in dealing with Covid-19

        WHO satisfied with Malaysia’s preparedness in dealing with Covid-19

        WHO satisfied with Malaysia’s preparedness in dealing with Covid-19 2

        PUTRAJAYA: The World Health Organisation (WHO) is pleased with Malaysia’s level of preparedness in handling the Covid-19 pandemic.

        Health director-general Datuk Dr Noor Hisham Abdullah (pix) said the matter was learned at a recent meeting between the WHO and the Ministry of Health (MOH).

        “What Malaysia is doing is the first method, the MCO (Movement Control Order),“ he told reporters at a media conference at MOH, here today.

        Dr Noor Hisham said Malaysia’s second method of controlling Covid-19 transmission was by conducting active case detection or identifying positive case patients – searching, testing, isolating and treating.

        In addition, Malaysia also identified the Covid-19 target groups – those who attended the tabligh gathering at the Sri Petaling Mosque, illegal immigrants and the Rohingya community, he said.

        He said the MoH had also consulted with the local authorities to carry out cleanup exercises of public areas which is expected to be implemented within the next two days.

        Asked about the number of doctors in Malaysia at the moment, he said so far there were enough doctors, and the ministry is in the process of recalling 3,000 retired nurses and health workers.

        “However, the MoH did not wait for all 3,000 retired medical personnel to come forward to register for employment. For example those who have skills in the Intensive Care Unit (ICU) and ward have been employed. More than 1,000 retired personnel are already placed in Sungai Buloh Hospital,” he said.

        Asked about the teleconference between MOH officials and doctors from China in the afternoon, Dr Noor Hisham said Malaysia wanted to know about the new method used by China in treating Covid-19.

        “For example the use of Avigan (medicine). The side effects need to be studied first. Even though it is not registered in Malaysia it can get the approval of the director-general of health,” he said.

        He added among the new methods shared by China is to use the blood of patients who have healed, as plasma to thicken the antibody.

        “But MoH is unsure whether this approach is effective or not,“ he added. – Bernama

        WHO satisfied with Malaysia’s preparedness in dealing with Covid-19
        Read More
        https://www.thesundaily.my/local/who-satisfied-with-malaysia-s-preparedness-in-dealing-with-covid-19-GL2184967

        Views: 0

      • Your Investing Life™: Step 2—Choosing the right asset mix

        Your Investing Life™: Step 2—Choosing the right asset mix

        Your target asset mix is like a bull’s-eye. Zero in on it, stay focused, and tune out the distractions around you so you can reach your goal.
        Your Investing Life™: Step 2—Choosing the right asset mix
        Read More
        https://investornews.vanguard/your-investing-life-step-2-choosing-the-right-asset-mix/

        Views: 0

      • Social Media Marketing Across the Globe

        With technology being as advanced as it is nowadays, it is very easy to reach your target audience members, no matter where they are. You most likely find it very easy to reach anyone you wish to reach no matter which country they inhabit…

        Read More
        http://www.associationofmarketing.org/articles/view.php?article_id=7939

        Views: 0

      • World TB Day 2020: It’s Time for solidarity

        World TB Day 2020: It’s Time for solidarity

        At this unique time in history when the world is grappling with the COVID-19 pandemic, the WHO Department of Global HIV, Hepatitis and STI Programmes stands in solidarity with governments and communities as they seek to maintain health services
        and continue to address the needs of patients suffering from HIV and tuberculosis (TB). 

        Despite being preventable and treatable, tuberculosis remains the world’s biggest infectious killer and the leading cause of death among people living with HIV (PLHIV), responsible for 32% of the 770 000 lives lost to HIV in 2018. People
        living with HIV are far more vulnerable (nearly 20 times more) to TB infection than people without HIV and are three times more likely to die during TB treatment.  

        While there are proven interventions that reduce TB deaths – such as provision of TB preventive treatment, adoption of novel diagnostics for earlier TB diagnosis and linkage to treatment, and antiretroviral therapy (ART) – we are far behind
        in scaling these up, and diagnostic and treatment gaps remain, with only half of estimated TB cases among PLHIV reaching care in 2018, only half of estimated PLHIV with TB receiving ART, and less than half of PLHIV new on ART initiating TB preventive
        treatment in a subset of countries which reported globally.

        On this World TB Day, WHO highlights two key interventions to reduce unnecessary TB deaths among PLHIV: 

        • (1) provision of TB preventive treatment for all eligible PLHIV; and 
        • (2) increased uptake of newer diagnostic tests such as the lateral flow urine lipoarabinomannan assay (TB-LAM.) 

        As the new Director for the Department of Global HIV, Hepatitis and STI Programmes, I support current efforts to continue and to take to scale TB activities. It’s Time for solidarity!

        -Meg Doherty, Director Global HIV, hepatitis and STI Programmes, WHO

        HIV programmes are encouraged to ensure that TB preventive treatment, including shorter WHO-recommended regimens, with updated guidance launched today, are provided to all eligible PLHIV as part of a routine package of care, including provision of ART, and that treatment completion is ensured.   

        In recent months, WHO has also released guidelines for use of a bedside urine TB-LAM test to accelerate earlier TB diagnosis, with significantly expanded eligibility criteria. As this test is “point of care” with the potential for earlier
        TB diagnosis and treatment initiation, HIV programmes should consider these recommendations as they enhance strategies for TB diagnosis among PLHIV, including as part of a routine package of advanced HIV care. 

        It’s Time to urgently scale up TB preventive treatment and TB diagnosis and strengthen referral and linkages to TB treatment at HIV service delivery points in all countries and continue to scale-up ART among PLHIV with TB. This applies to all populations
        at risk, including children, pregnant women and marginalized groups, to ensure no one is left behind.

        WHO calls for continued collaboration in countries across health programmes for harmonized and integrated policies and service delivery, and engagement with communities and other sectors. Unless HIV programmes scale up interventions to close these
        gaps in prevention, diagnosis and treatment both for TB and HIV, countries and their development partners will not meet our common target: a 75% reduction in TB deaths among PLHIV between 2010 and 2020. HIV mortality cannot be reduced without addressing
        the leading cause: tuberculosis.

         

        World TB Day 2020: It’s Time for solidarity
        Read More
        https://www.who.int/news-room/detail/24-03-2020-world-tb-day-2020-it-s-time-for-solidarity

        Views: 0

      • New WHO recommendations to prevent tuberculosis aim to save millions of lives

        Geneva –  New World Health Organization (WHO) guidance will help countries accelerate efforts to stop people with tuberculosis (TB) infection becoming sick with TB by giving them preventive treatment.

        A quarter of the world‘s population is estimated to be infected with TB bacteria. These people are neither sick nor contagious. However, they are at greater risk of developing TB disease, especially those with weakened immunity. Offering them TB
        preventive treatment will not only protect them from becoming sick but also cut down on the risk of transmission in the community.  

        As we mark World TB Day 2020, the disease remains the world’s top infectious killer. In 2018, 10 million people fell ill with TB worldwide and 1.5 million people lost their lives to this disease.

        “COVID-19 is highlighting just how vulnerable people with lung diseases and weakened immune systems can be,“ said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “The world committed to end TB by 2030; improving prevention is key
        to making this happen. Millions of people need to be able to take TB preventive treatment to stop the onset of disease, avert suffering and save lives”.

        Dr Tedros highlighted the importance to continue efforts to tackle longstanding health problems, including TB during global outbreaks such as COVID-19. At the same time, programmes already in place to combat TB and other major infectious diseases
        can be leveraged to make the response to COVID-19 more effective and rapid.

        Although some progress has been made towards targets set at the UN high-level Meeting on TB in 2018, TB preventive treatment has been largely neglected. Global leaders committed to ensuring access to TB preventive treatment to at least 24 million contacts
        of people with active TB and 6 million people living with HIV by 2022.  To date only a fraction of that target has been reached, with countries putting less than 430,000 contacts and 1.8 million people on TB preventive treatment in 2018.

        TB remains the top cause of death among people with HIV. TB preventive treatment works synergistically with antiretroviral therapy to prevent TB and save lives. Reinvigorated efforts by governments, health services, partners, donors and civil society
        will be needed to increase access to TB preventive treatment to the levels targeted.

        The new consolidated guidelines recommend a range of innovative approaches to scale up access to TB preventive treatment:

        • WHO recommends a scale-up of TB preventive treatment among populations at highest risk including household contacts of TB patients, people living with HIV and other people at risk with lowered” immunity or living in crowded settings.
        • WHO recommends an integration of TB preventive treatment services into ongoing case finding efforts for active TB. All household contacts of TB patients and people living with HIV are recommended to be screened
          for active TB. If active TB is ruled out, they should be initiated on TB preventive treatment.
        • WHO recommends that either a tuberculin skin test  or interferon-gamma release assay (IGRA) be used to test for TB infection. Both tests are helpful to find people more likely to benefit from TB preventive treatment
          but should not become a barrier to scale-up access. Testing for TB infection is not required before starting TB preventive treatment in people living with HIV, and children under 5 years who are contacts of people with active TB.
        • WHO recommends new shorter options for preventive treatment in addition to the widely used 6 months of daily isoniazid. The shorter options that are now recommended range from a 1 month daily regimen of rifapentine plus isoniazid
          to 3 months weekly rifapentine plus isoniazid, 3 months daily rifampicin plus isoniazid, or 4 months of daily rifampicin alone.

        “As people around the globe come together to commemorate World TB Day, WHO is calling on governments, affected communities, civil society organizations, health-care providers, donors, partners and the industry to unite forces and step up
        the TB response – notably for TB preventive treatment – to ensure no one is left behind,” said Dr Tereza Kasaeva, Director of WHO’s Global TB Programme. “The new WHO guidance shows the way forward for millions to rapidly
        access new tools and shorter, safer options for preventive treatment. The time for action is now.”

        TB preventive treatment is an affordable intervention that can prevent families from sliding into poverty and preserve the health and economy of whole communities. WHO anticipates that as new and safer drugs come onto the markets, and as prices
        fall, it will become a highly-cost effective way to save millions of lives.

         

        NOTES FOR EDITORS:

        WORK BY WHO AND PARTNERS

        WHO works closely with Member States including the US Government and technical and funding partners such as UNITAID to enhance access to shorter TB preventive treatment regimens. UNITAID-supported projects such as IMPAACT4TB and Cap-TB projects
        enabled by WHO with partners in Brazil, Cambodia, Cameroon, Côte d’Ivoire, Democratic Republic of Congo, Ethiopia, Ghana, India, Indonesia, Kenya, Lesotho, Malawi, Mozambique, South Africa, Uganda, United Republic of Tanzania and
        Zimbabwe are leading the way. The new treatment options are also now more affordable, thanks to the significant price drop of rifapentine – a key drug – facilitated recently by UNITAID, the Global Fund to Fight AIDS, Tuberculosis and Malaria
        and global biopharmaceutical company Sanofi, along with forthcoming arrangements underway with generic manufacturers.

        MORE ABOUT THE GUIDELINES

        The new consolidated WHO guidelines come with an operational handbook to help guide countries step-by-step as they take TB preventive treatment to scale. This includes guidance on how to prioritize and invest from demand creation for TB prevention
        to supervision and monitoring of the programme.

        The guidelines and operational handbook are also accompanied by an innovative mobile application – Prevent TB –to help health-care workers manage TB preventive treatment in their communities. Its online dashboard allows programme
        managers to visualize and monitor data in real time. The application can be customized by countries to suit their specific settings and is currently being adopted in India and Philippines.

        WORLD TB DAY

        The new guidelines and tools are being released ahead of World TB Day. World TB Day is observed on March 24 each year to raise public awareness and understanding about the world’s deadliest infectious killer – TB and its devastating
        health, social and economic impact on people around the world. Under the theme “It’s Time”, the spotlight this year is on urgently accelerating the TB response to save lives and end suffering.

        Read More
        https://www.who.int/news-room/detail/24-03-2020-new-who-recommendations-to-prevent-tuberculosis-aim-to-save-millions-of-lives

        Views: 0